Ana Ferrer
University of Barcelona
12 Papers
249 Citations
Ana Ferrer is an academic researcher from University of Barcelona. The author has contributed to research in topics: Mantle cell lymphoma & Immunophenotyping. The author has an hindex of 9, co-authored 12 publications.
Chat about Author
Papers
Nuclear Survivin Expression in Mantle Cell Lymphoma Is Associated with Cell Proliferation and Survival
Antonio Martinez,Beatriz Bellosillo,Francesc Bosch,Ana Ferrer,Silvia Marcé,Neus Villamor,German Ott,Emili Montserrat,Elias Campo,Dolors Colomer +9 more
TL;DR: The findings indicate that survivin is commonly expressed in MCL with a nuclear and mitotic pattern, suggesting a potential role in cell cycle regulation and tumor progression.
cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas.
Silvia Hernández,Luis Hernández,Sílvia Beà,Magda Pinyol,Iracema Nayach,Beatriz Bellosillo,Alfons Nadal,Ana Ferrer,Pedro L. Fernández,Emili Montserrat,Antonio Cardesa,Elias Campo +11 more
TL;DR: It is suggested that cdc25A and ‐B2, but not cDC25B1, ‐b2, B3 and C, are over‐expressed in a relatively large number of malignant lymphomas and may participate in the pathogenesis of aggressive variants.
69
c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.
Lluis Hernández,Silvia Hernández,Sílvia Beà,M. Pinyol,Ana Ferrer,Francesc Bosch,Alfons Nadal,Pedro L. Fernández,Antonio Palacín,Emili Montserrat,Elias Campo +10 more
TL;DR: Results indicate that c-myc is overexpressed in a subset of MCL, but structural gene alterations are less frequent than in other nodal NHL.
55
Incidence and Clinical Significance of Bcl-2 / IgH Rearrangements in Follicular Lymphoma
Silvia Montoto,Armando López-Guillermo,Dolors Colomer,Jordi Esteve,Francesc Bosch,Ana Ferrer,Neus Villamor,Carolina Moreno,Elias Campo,Emili Montserrat +9 more
TL;DR: In this series bcl-2 / IgH rearrangement at MBR or mcr, which was found in 67% of the patients, was not correlated with response to treatment, survival nor time-to-treatment-failure.
45
Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Francisco Plancarte,Armando López-Guillermo,Leonor Arenillas,Silvia Montoto,Eva Giné,Ana Muntañola,Ana Ferrer,Neus Villamor,Francesc Bosch,Lluis Colomo,Olga Balaguer,Elias Campo,Emili Montserrat +12 more
TL;DR: Although the majority of patients with localized FL achieve CR, the risk of relapse is high and the FLIPI is of prognostic value in these patients, and theFLIPI was the sole variable predicting OS.
39